0576-88813233
产品描述:
AM095是LPA1受体的拮抗剂,对人源重组的LPA1和小鼠LPA1的IC50分别为0.98 μM和0.73 μM。
产品别名:
[4'-[3-甲基-4-[[[((R)-1-苯基乙基)氧基]羰基]氨基]异恶唑-5-基]联苯-4-基]乙酸
[1]. Castelino FV, et al. Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of scleroderma. Arthritis Rheum. 2011 May;63(5):1405-15.
[2]. Ruisanchez E, et al. Lysophosphatidic acid induces vasodilation mediated by LPA1 receptors, phospholipase C, and endothelial nitric oxide synthase. FASEB J. 2014 Feb;28(2):880-90.
版权所有 Copyright(C) 2018-2024 台州市科瑞生物技术有限公司